Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent …
C Janoir, A Lepoutre, L Gutmann… - Open forum infectious …, 2016 - academic.oup.com
Abstract Background. In 2010, the pneumococcal 13-valent conjugate vaccine (PCV13),
containing 6 additional serotypes including the multidrug-resistant 19A, replaced the PCV7 …
containing 6 additional serotypes including the multidrug-resistant 19A, replaced the PCV7 …
Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012–2014) despite continued reductions in other 13-valent conjugate …
AN Horácio, C Silva-Costa, JP Lopes… - Frontiers in …, 2016 - frontiersin.org
Since 2010 the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent
vaccine (PCV7) as the leading pneumococcal vaccine used in children through the private …
vaccine (PCV7) as the leading pneumococcal vaccine used in children through the private …
[HTML][HTML] Characterization of emerging serotype 19A pneumococcal strains in invasive disease and carriage, Belgium
S Desmet, H Theeten, L Laenen… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
After switching from 13-valent to 10-valent pneumococcal conjugate vaccine (PCV10)(2015–
2016) for children in Belgium, we observed rapid reemergence of serotype 19A invasive …
2016) for children in Belgium, we observed rapid reemergence of serotype 19A invasive …
Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal …
L Setchanova, A Alexandrova, D Pencheva… - Journal of Global …, 2018 - Elsevier
Abstract Objectives Pneumococcal conjugate vaccines (PCVs) have reduced the incidence
of pneumococcal disease, but non-vaccine serotypes are of concern, particularly if …
of pneumococcal disease, but non-vaccine serotypes are of concern, particularly if …
[HTML][HTML] Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in …
A González-Díaz, J Càmara, M Ercibengoa… - Clinical Microbiology …, 2020 - Elsevier
Objective An early reduction of adult invasive pneumococcal disease (IPD) was observed
after the 13-valent pneumococcal conjugate vaccine (PCV13) introduction for children in …
after the 13-valent pneumococcal conjugate vaccine (PCV13) introduction for children in …
Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing pneumococci in the PCV7 era in Portugal
AS Simoes, L Pereira, S Nunes… - Journal of clinical …, 2011 - Am Soc Microbiol
The introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) in Portugal
led to extensive serotype replacement among carriers of pneumococci, with a marked …
led to extensive serotype replacement among carriers of pneumococci, with a marked …
Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France
C Janoir, R Cohen, C Levy, E Bingen, A Lepoutre… - PLoS …, 2014 - journals.plos.org
In France, the use of the 7-valent pneumococcal conjugate vaccine (PCV7) lead to an
overall significant decrease in PCV7 invasive pneumococcal disease (IPD) incidence …
overall significant decrease in PCV7 invasive pneumococcal disease (IPD) incidence …
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review
TTH Myint, H Madhava, P Balmer, D Christopoulou… - Advances in …, 2013 - Springer
Introduction Streptococcus pneumoniae can cause invasive pneumococcal diseases (IPD),
such as bacteremic pneumonia, bacteremia, meningitis, and sepsis, and non-IPDs, such as …
such as bacteremic pneumonia, bacteremia, meningitis, and sepsis, and non-IPDs, such as …
Changes in invasive pneumococcal disease spectrum after 13-valent pneumococcal conjugate vaccine implementation
C Levy, E Varon, N Ouldali, S Béchet… - Clinical Infectious …, 2020 - academic.oup.com
Background Pneumococcal conjugate vaccine (PCV) implementation has led to a sharp
decrease in invasive pneumococcal disease (IPD) due to the reduction in PCV serotypes …
decrease in invasive pneumococcal disease (IPD) due to the reduction in PCV serotypes …
Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
S Desmet, K Lagrou, C Wyndham-Thomas… - The Lancet Infectious …, 2021 - thelancet.com
Background Ten-valent and 13-valent pneumococcal conjugate vaccines (PCVs) have
shown important benefits by decreasing invasive pneumococcal disease caused by vaccine …
shown important benefits by decreasing invasive pneumococcal disease caused by vaccine …